These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 9774878)
1. [Evaluation on non invasive diagnostic tests for the second look in epithelial ovarian cancer]. García Enguídanos A; Crespo Azanza E; Díaz Recaséns J; Lobo Samper F; Jorge Herrero JA; Sáinz de la Cuesta Abbad R Rev Clin Esp; 1998 Aug; 198(8):502-5. PubMed ID: 9774878 [TBL] [Abstract][Full Text] [Related]
2. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma. Littell RD; Hallonquist H; Matulonis U; Seiden MV; Berkowitz RS; Duska LR Gynecol Oncol; 2006 Nov; 103(2):570-4. PubMed ID: 16769104 [TBL] [Abstract][Full Text] [Related]
3. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy. Fagotti A; Fanfani F; Rossitto C; Lorusso D; De Gaetano AM; Giordano A; Vizzielli G; Scambia G Oncology; 2008; 75(3-4):152-8. PubMed ID: 18827492 [TBL] [Abstract][Full Text] [Related]
4. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer. Bozkurt N; Yuce K; Basaran M; Kose F; Ayhan A Obstet Gynecol; 2004 Jan; 103(1):82-5. PubMed ID: 14704249 [TBL] [Abstract][Full Text] [Related]
5. Abdominal recurrence of ovarian cancer: value of abdominal MR in patients with positive CA125 and negative CT. Balestreri L; Bison L; Sorio R; Morra A; Campagnutta E; Morassut S Radiol Med; 2002; 104(5-6):426-36. PubMed ID: 12589264 [TBL] [Abstract][Full Text] [Related]
6. [The value of preoperative diagnosis before second-look laparotomy in ovarian cancer]. Meden H; Rath W; Ohlmeyer D Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):101-5. PubMed ID: 2180783 [TBL] [Abstract][Full Text] [Related]
7. Monitoring cancer antigen 125 levels in induction chemotherapy for epithelial ovarian carcinoma and predicting outcome of second-look procedure. Folk JJ; Botsford M; Musa AG Gynecol Oncol; 1995 May; 57(2):178-82. PubMed ID: 7729730 [TBL] [Abstract][Full Text] [Related]
8. Predictive value of PET-CT imaging versus AGO-scoring in patients planned for cytoreductive surgery in recurrent ovarian cancer. Lenhard SM; Burges A; Johnson TR; Kirschenhofer A; Bruns C; Linke R; Friese K Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):263-8. PubMed ID: 18614272 [TBL] [Abstract][Full Text] [Related]
11. Predictive value of the combined serum CA 125 and TPS during chemotherapy and before second-look laparotomy in epithelial ovarian cancer. Senapad S; Neungton S; Thirapakawong C; Suphanit I; Hangsubcharoen M; Thamintorn K Anticancer Res; 2000; 20(2B):1297-300. PubMed ID: 10810438 [TBL] [Abstract][Full Text] [Related]
12. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer. Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445 [TBL] [Abstract][Full Text] [Related]
13. Second look for ovarian cancer: laparoscopy or Laparotomy? A prospective comparative study. Clough KB; Ladonne JM; Nos C; Renolleau C; Validire P; Durand JC Gynecol Oncol; 1999 Mar; 72(3):411-7. PubMed ID: 10053115 [TBL] [Abstract][Full Text] [Related]
14. [Computed tomography and tumor markers as diagnostic alternatives to second-look surgery in the treatment of malignant ovarian tumors]. La Fianza A; Campani R; Dore R; Babilonti L; Torretta L Radiol Med; 1992 Apr; 83(4):374-82. PubMed ID: 1603993 [TBL] [Abstract][Full Text] [Related]
15. The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer. Alvarez Secord A; Sayer R; Snyder SA; Broadwater G; Rodriguez GC; Berchuck A; Blackwell K Gynecol Oncol; 2004 Jul; 94(1):74-9. PubMed ID: 15262122 [TBL] [Abstract][Full Text] [Related]
16. Predictive and prognostic values of cancer-associated serum antigen (CASA) and cancer antigen 125 (CA 125) levels prior to second-look laparotomy for ovarian cancer. Kierkegaard O; Mogensen O; Mogensen B; Jakobsen A Gynecol Oncol; 1995 Nov; 59(2):251-4. PubMed ID: 7590482 [TBL] [Abstract][Full Text] [Related]
17. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients. Obermair A; Sevelda P Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220 [TBL] [Abstract][Full Text] [Related]
18. Plasma lipid-associated sialic acid and serum CA 125 as indicators of disease status with advanced ovarian cancer. Vardi JR; Tadros GH; Foemmel R; Shebes M Obstet Gynecol; 1989 Sep; 74(3 Pt 1):379-83. PubMed ID: 2761915 [TBL] [Abstract][Full Text] [Related]
19. [Technique and preliminary results in second-look laparoscopy in epithelial malignant ovarian tumors]. Canis M; Chapron C; Mage G; Pouly JL; Wattiez A; Bassil S; Raymond F; Bruhat MA J Gynecol Obstet Biol Reprod (Paris); 1992; 21(6):655-63. PubMed ID: 1430912 [TBL] [Abstract][Full Text] [Related]
20. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival. Friedman RL; Eisenkop SM; Wang HJ Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]